The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Development of Chromosome 1q+ Specific Treatment for Highest Risk Pediatric Posterior Fossa Ependymoma.
|
---|---|
Published in |
Clinical Cancer Research, February 2024
|
DOI | 10.1158/1078-0432.ccr-23-3156 |
Pubmed ID | |
Authors |
Andrea M Griesinger, Annaliese J Calzadilla, Enrique Grimaldo, Andrew M Donson, Vladimir Amani, Angela M Pierce, Jenna Steiner, Soudabeh Kargar, Natalie J Serkova, Kelsey C Bertrand, Karen D Wright, Rajeev Vibhakar, Todd Hankinson, Michael Handler, Holly B Lindsay, Nicholas K Foreman, Kathleen Dorris |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 20% |
Austria | 1 | 20% |
Unknown | 3 | 60% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 60% |
Science communicators (journalists, bloggers, editors) | 2 | 40% |
Mendeley readers
The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 6 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 2 | 33% |
Student > Ph. D. Student | 1 | 17% |
Unspecified | 1 | 17% |
Researcher | 1 | 17% |
Student > Doctoral Student | 1 | 17% |
Other | 0 | 0% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 2 | 33% |
Medicine and Dentistry | 2 | 33% |
Neuroscience | 1 | 17% |
Unspecified | 1 | 17% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 August 2024.
All research outputs
#15,331,591
of 26,495,046 outputs
Outputs from Clinical Cancer Research
#10,020
of 13,472 outputs
Outputs of similar age
#148,139
of 386,444 outputs
Outputs of similar age from Clinical Cancer Research
#78
of 121 outputs
Altmetric has tracked 26,495,046 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,472 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 386,444 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 121 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.